Inpatient management of thrombosis and hemostasis in patients with cirrhosis [0.03%]
肝硬化患者住院期间的血栓和止血管理
Russel Roark,Ragesh B Thandassery
Russel Roark
Hepatotoxicity in inflammatory bowel disease: Immunomodulators, biologics, and beyond [0.03%]
炎症性肠病的肝毒性：免疫调节剂、生物制剂及其他
Helgi K Björnsson,Einar S Björnsson
Helgi K Björnsson
The role of patient-reported outcomes in a patient-centered care model for managing chronic liver diseases [0.03%]
以患者为中心的慢性肝病管理模式中患者报告结果的作用
Manisha Verma,Archita P Desai
Manisha Verma
Management of patients with CHB outside the guidelines: Insights from Egyptian cohort with long-term follow-up [0.03%]
埃及慢性乙型肝炎患者长期随访队列的诊疗特点及启示
Gamal Shiha,Riham Soliman,Ayman Hassan et al.
Gamal Shiha et al.
It is alarming that globally, only 2.2% (6.6 million) of patients with chronic hepatitis B (CHB) received treatment in 2019. One contributing factor to this low treatment rate is the complexity and restrictive nature of clinical practice gu...
Valentina Zanuso,Angelo Pirozzi,Giulia Tesini et al.
Valentina Zanuso et al.
Huey-Ling Chen
Huey-Ling Chen
A severe case of hypercalcemia in a patient with presumed cryptogenic cirrhosis [0.03%]
疑似特发性肝硬化的患者出现严重高钙血症病例报告
Agnieszka Maniak,Nancy Reau
Agnieszka Maniak
Dirk J van Leeuwen
Dirk J van Leeuwen
(P)rehabilitation in advanced chronic liver disease (advCLD): From basic exercise concepts to implementation challenges [0.03%]
终末期肝病康复：从基本锻炼概念到实施挑战
Andrew P Kassa,Jonathan G Stine
Andrew P Kassa
Noncirrhotic portal hypertension-Historical perspectives bring clarity to the entity and its management [0.03%]
非肝硬化门脉高压症——历史回顾使该病的诊断和治疗更加清晰
Cyriac Abby Philips,Shiv K Sarin
Cyriac Abby Philips